Tag: NASDAQ:MDGL

January 2, 2020

Biotech Outlook 2020: Washington Scrutiny Looms Over Sector

INN offers a closer look at the path ahead for biotech investors in 2020 as new challenges arise for the...
June 7, 2018

Madrigal Pharmaceuticals Prices Public Offering of Common Stock

Madrigal Pharmaceuticals (Nasdaq:MDGL), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates for the treatment...
June 6, 2018

Madrigal Pharmaceuticals Announces Proposed Public Offering of Common Stock

Madrigal Pharmaceuticals (Nasdaq:MDGL), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates for the treatment...
October 9, 2016

5 Top NASDAQ Biotech Stocks: Aurinia Pharmaceuticals Up 90 Percent Year-To-Date

Last week's top gainer was Aurinia Pharmaceuticals, followed by Neptune Tech & Bioresources, Madrigal Pharmaceuticals, Biodel and Curis